Detailed Summary

Key Corporate Actions Approved

1. Rights Issue Approval

  • The Board approved raising funds through issuance of equity shares (face value ₹10 each) via rights issue
  • Maximum issue size: ₹50 Crores (Rupees Fifty Crores only)
  • To be offered to eligible equity shareholders as on record date (to be determined subsequently)
  • Subject to statutory/regulatory approvals under SEBI (Issuer of Capital and Disclosure Requirements) Amendment Regulations, 2025
  • Detailed terms including issue price, rights entitlement ratio, record date, and payment terms to be determined later by Board/Rights Issue Committee

2. Rights Issue Committee Constitution

  • Committee formed for issue, offer, and allotment of Equity Shares
  • Composition: Mr. Rajnish Kumar Pandey (Executive Director), Mr. Abhay Sethia (Non-executive Independent Director), Ms. Lucy Massey (Non-executive Non-Independent Director)

3. Financial Results

  • Standalone Unaudited Financial Results for quarter ended June 30, 2026 approved
  • Results reviewed by Audit Committee and approved by Board
  • Compliance with Regulation 33 of SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015

4. Software Acquisition

  • Acquisition of commercial rights to two software applications from Onelife Capital Advisors Limited (OCAL)
  • Applications: "Ready Shopping" (shopping businesses) and "Ready Pharmacy" (pharmacy businesses)
  • Fixed License Fee: ₹53,99,603 (Rupees Fifty-Three Lakh Ninety-Nine Thousand Six Hundred and Three only)
  • Includes all operational concepts, commercial workflows, methodologies, and proprietary business know-how
  • Additional Royalty: 0.50% of Gross Revenue payable quarterly for ongoing strategic guidance and business development support

5. Rights Issue Appointments

  • Registrar: Purva Sharegistry (India) Private Limited (SEBI Registration No. INR000001112)
  • Banker: ICICI Bank Limited (as Banker to the Issue/Escrow Collection Bank/Refund Bank)
  • Escrow Account: Opened with ICICI Bank
  • Monitoring Agency: Acuite Ratings & Research Limited

6. Internal Auditor Appointment

  • Aadhar Agarwal & Co., Chartered Accountants appointed as Internal Auditor for Financial Year 2026-27

7. Management Changes

  • Resignation: Ms. Jyoti Darade (ACS70171) as Company Secretary & Compliance Officer effective April 15, 2026
  • Appointment: Ms. Anushree Tekriwal (ICSI Membership No. A25243) as Company Secretary and Key Managerial Personnel effective July 15, 2026

8. Director Changes

  • Resignation: Ms. Khusbu Agrawal (DIN 09847254) as Independent Director effective July 15, 2026
  • Appointment: Dr. Ranu Jain (DIN: 11012104) as Non-Executive Independent Additional Director for 1-year term effective July 15, 2026
  • Appointment: Mr. Santosh Bhattacharjee (DIN: 02447452) as Non-Executive Independent Additional Director for 1-year term effective July 15, 2026

9. Related Party Transaction

  • Approval to take approximately 1,500 sq. ft. premises on leave and license from Dealmoney Commodities Private Limited (DCPL)
  • Location: 1st Floor, Plot No. A-356 & 357, Road No. 26, Wagle Estate, Thane (West)
  • Terms: ₹1,50,00,000 refundable, interest-free security deposit with monthly rental of ₹5,000
  • Under omnibus approval for related party transactions up to ₹10 crore for FY 2026-27

Meeting Details

  • Board meeting commenced at 11:00 a.m. and concluded at 23:30 p.m. on July 15, 2026